medmix AG – Trademark Portfolio
Entity Type: 99
medmix AG holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 20 (Furniture) across 12 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include INENGA and MEDMIX.
Neuhofstrasse 20
CH-6340 Baar
Showing of trademarks Trademarks
Trademark Classifications
medmix AG's trademark portfolio spans 12 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Legal services; security services for the protection of property and individuals
Machines and machine tools; motors and engines; machine coupling and transmission components
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does medmix AG have?
medmix AG has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does medmix AG file in?
medmix AG files trademarks across 12 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 20 (Furniture), Class 8 (Hand Tools), Class 21 (Housewares), Class 45 (Legal & Security Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are medmix AG's most well-known trademarks?
medmix AG's registered trademark portfolio includes well-known marks such as INENGA and MEDMIX. These are among 4 currently registered trademarks in the portfolio.
What is medmix AG's trademark registration success rate?
medmix AG has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.